Multiple Trauma: Clinical Trials

11 trials for Multiple Trauma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 3 completed, 1 enrolling by invitation, 1 suspended. 11 Phase 2, 4 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 211Unknown 4, Completed 3, Enrolling by invitation 1, Suspended 1, Terminated 1, Withdrawn 1
Phase 14Completed 1, Enrolling by invitation 1, Suspended 1, Terminated 1
Phase 32Completed 1, Withdrawn 1

Follow Multiple Trauma: new trials by email Literature Review of Multiple Trauma trials Research Report on Multiple Trauma

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Norepinephrine in Trauma Patients With Hemorrhagic Shock
Norepinephrine, Placebo - Trauma, Multiple
Phase 1 / Phase 2Enrolling by invitationVisarat Palitnonkiat402025-05-202025-05-18
Role of Active Deresuscitation After Resuscitation:
Furosemide Injection, Metolazone Tablets - Fluid Overload, Critical Illness
Phase 2UnknownUnity Health Toronto1202024-05-012024-03-22
Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Intensive Rehabilitation
Placebo, Oxycodone, Essential Oil - Spinal Cord Injuries, Polytrauma
Phase 2CompletedSpaulding Rehabilitation Hospital202019-02-202026-08-04
Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.
Fibrinogen Concentrate (Human) 1 MG [RiaSTAP], Red blood cells concentrate, Tranexamic Acid - Polytrauma, Traumatic Hemorrhage
Phase 1 / Phase 2CompletedBanc de Sang i Teixits792018-11-212024-01-25
Vitamin D and Bone Homeostasis in Ortho Polytrauma Patients
Ergocalciferol 8000 IU/ML Oral Liquid [DRISDOL], Propylene Glycol - Vitamin D Deficiency, Polytrauma
Phase 1 / Phase 2SuspendedNew York City Health and Hospitals Corporation602017-07-012019-04-04
Pre-Hospital Use of Plasma for Traumatic Hemorrhage
Plasma, Normal saline - Shock, Hemorrhagic
Phase 2 / Phase 3WithdrawnVirginia Commonwealth University2014-11-012016-02-23
Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients
Omega-3, Placebo - Multiple Trauma
Phase 1 / Phase 2TerminatedUniversity of Cincinnati122011-06-012013-02-25
Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients
erythropoietin, placebo - Multiple Trauma
Phase 2UnknownTehran University of Medical Sciences202007-07-012010-11-18
Treatment of Polytraumatisms With Corticoids
hydrocortisone, NaCl - Polytraumatism
Phase 2 / Phase 3CompletedNantes University Hospital1502006-11-012026-09-14
Use of Beta Blockers in Elderly Trauma Patients
Esmolol, Metoprolol - Multiple Trauma, Cardiovascular Diseases
Phase 2UnknownUniversity of Texas Southwestern Medical Center1482005-12-012007-05-10
A Single Site Safety and Tolerability Study of HBOC-201 in Trauma Subjects
Hemoglobin-based oxygen carrier-201 (HBOC 201), Standard of Care - Wounds and Injuries
Phase 2UnknownBiopure Corporation532004-07-012008-03-06

Narrower conditions

Wounds and Injuries (5)  ·  Agnosia (1)  ·  Burns (1)  ·  Cardiovascular Diseases (1)  ·  Critical Illness (1)  ·  Edema (1)  ·  Hemorrhage (1)  ·  Musculoskeletal Diseases (1)  ·  Respiratory Distress Syndrome (1)  ·  Sepsis (1)  ·  Shock (1)  ·  Shock, Hemorrhagic (1)  ·  Spinal Cord Injuries (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Wounds and Injuries (6)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Avitaminosis (1)  ·  Central Nervous System Diseases (1)  ·  Deficiency Diseases (1)  ·  Disease Attributes (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Lung Diseases (1)  ·  Malnutrition (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)

Interventions

Docosahexaenoic Acids (1)  ·  Epoetin Alfa (1)  ·  Ergocalciferols (1)  ·  Erythropoietin (1)  ·  Fibrinogen (1)  ·  Fluid Therapy (1)  ·  Furosemide (1)  ·  HBOC 201 (1)  ·  Hydrocortisone (1)  ·  Metolazone (1)  ·  Metoprolol (1)  ·  Norepinephrine (1)  ·  Oils, Volatile (1)  ·  Oxycodone (1)  ·  Propylene Glycol (1)

Sponsors

Banc de Sang i Teixits (1)  ·  Biopure Corporation (1)  ·  Nantes University Hospital (1)  ·  New York City Health and Hospitals Corporation (1)  ·  Spaulding Rehabilitation Hospital (1)  ·  Tehran University of Medical Sciences (1)  ·  Unity Health Toronto (1)  ·  University of Cincinnati (1)  ·  University of Texas Southwestern Medical Center (1)  ·  Virginia Commonwealth University (1)  ·  Visarat Palitnonkiat (1)

Countries

United States (5)  ·  Canada (1)  ·  France (1)  ·  Iran (1)  ·  South Africa (1)  ·  Spain (1)  ·  Thailand (1)

Top investigators

A. Gerson Greenburg, MD, PhD (1)  ·  Bruce D Spiess, MD, FAHA (1)  ·  John C Marshall, MD (1)  ·  Krishna Athota, MD (1)  ·  Mahe Joachim, MD (1)  ·  Milan Sen, MD (1)  ·  Professor Ken D Boffard, MD (1)  ·  Randall Friese, MD (1)  ·  Richard Branson, MSc (1)  ·  Ross D Zafonte, DO (1)

Results publications

PMID 18404076, PMID 21427372, PMID 22777514, PMID 23450051, PMID 26220293, PMID 28183347